The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-Hydroxyvitamin D3 in human hypertension

Clinical Endocrinology

Volumn 74, Issue 3, 2011, Pages 294-299

  Vaidya, Anand ^a   Pojoga, Luminita ^a   Underwood, Patricia C ^a,b   Forman, John P ^a,c   Hopkins, Paul N ^c   Williams, Gordon H ^a   Williams, Jonathan S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON COLLEGE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CALCIFEDIOL; GLUCOSE; INSULIN; RESISTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HIGH SODIUM INTAKE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; SODIUM BALANCE; SODIUM INTAKE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; VITAMIN INTAKE;

ADULT; AGED; BLOOD PRESSURE; CALCIFEDIOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM; RESISTIN; SODIUM, DIETARY;

EID: 79851471119     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03922.x     Document Type: Article

References (41)

1. Kershaw, E.E., &, Flier, J.S., (2004) Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism, 89, 2548-2556. (Pubitemid 38766330)
2. Steppan, C.M., Bailey, S.T., Bhat, S., et al. (2001) The hormone resistin links obesity to diabetes. Nature, 409, 307-312. (Pubitemid 32151228)
3. McTernan, C.L., McTernan, P.G., Harte, A.L., et al. (2002) Resistin, central obesity, and type 2 diabetes. Lancet, 359, 46-47. (Pubitemid 34119198)
4. Nagaev, I., &, Smith, U., (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochemical and Biophysical Research Communications, 285, 561-564. (Pubitemid 32918109)
5. Lee, J.H., Chan, J.L., Yiannakouris, N., et al. (2003) Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. Journal of Clinical Endocrinology and Metabolism, 88, 4848-4856. (Pubitemid 37357535)
6. Heilbronn, L.K., Rood, J., Janderova, L., et al. (2004) Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. Journal of Clinical Endocrinology and Metabolism, 89, 1844-1848. (Pubitemid 38507943)
7. Stumvoll, M., &, Haring, H., (2002) Resistin and adiponectin-of mice and men. Obesity Research, 10, 1197-1199.
8. Savage, D.B., Sewter, C.P., Klenk, E.S., et al. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes, 50, 2199-2202. (Pubitemid 33641901)
9. Owecki, M., Miczke, A., Nikisch, E., et al. (2010) Serum resistin concentrations are higher in human obesity but independent from insulin resistance. Experimental and Clinical Endocrinology & Diabetes. Epub 2010 Sep 8.
10. Fain, J.N., Cheema, P.S., Bahouth, S.W., et al. (2003) Resistin release by human adipose tissue explants in primary culture. Biochemical and Biophysical Research Communications, 300, 674-678. (Pubitemid 36268889)
11. Yang, R.Z., Huang, Q., Xu, A., et al. (2003) Comparative studies of resistin expression and phylogenomics in human and mouse. Biochemical and Biophysical Research Communications, 310, 927-935. (Pubitemid 37188711)
12. Curat, C.A., Wegner, V., Sengenes, C., et al. (2006) Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia, 49, 744-747. (Pubitemid 43357549)
13. Yiannikouris, F., Gupte, M., Putnam, K., et al. (2010) Adipokines and blood pressure control. Current Opinion in Nephrology and Hypertension, 19, 195-200.
14. Takata, Y., Osawa, H., Kurata, M., et al. (2008) Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension, 51, 534-539. (Pubitemid 351156444)
15. Thomopoulos, C., Daskalaki, M., Papazachou, O., et al. (2010) Association of resistin and adiponectin with different clinical blood pressure phenotypes. Journal of Human Hypertension. Epub 2010 Mar 4.
16. Zhang, L., Curhan, G.C., &, Forman, J.P., (2010) Plasma resistin levels associate with risk for hypertension among nondiabetic women. Journal of the American Society of Nephrology, 21, 1185-1191.
17. Frankel, D.S., Vasan, R.S., D'Agostino Sr, R.B., et al. (2009) Resistin, adiponectin, and risk of heart failure the Framingham offspring study. Journal of the American College of Cardiology, 53, 754-762.
18. Kim, S., Soltani-Bejnood, M., Quignard-Boulange, A., et al. (2006) The Adipose Renin-Angiotensin System Modulates Systemic Markers of Insulin Sensitivity and Activates Intrarenal Renin-Angiotensin System. Journal of Biomedicine and Biotechnology, 5, 1-6.
19. Iacobellis, G., Petramala, L., Cotesta, D., et al. (2010) Adipokines and cardiometabolic profile in primary hyperaldosteronism. Journal of Clinical Endocrinology and Metabolism, 95, 2391-2398.
20. Vaidya, A., &, Forman, J.P., (2010) Vitamin D and hypertension: current controversies and future directions. Hypertension, 56, 774-779.
21. Li, Y.C., Kong, J., Wei, M., et al. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Journal of Clinical Investigation, 110, 229-238. (Pubitemid 34787360)
22. Li, Y.C., (2003) Vitamin D regulation of the renin-angiotensin system. Journal of Cellular Biochemistry, 88, 327-331. (Pubitemid 36119906)
23. Resnick, L.M., Muller, F.B., &, Laragh, J.H., (1986) Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Annals of Internal Medicine, 105, 649-654. (Pubitemid 17176965)
24. Resnick, L.M., Nicholson, J.P., &, Laragh, J.H., (1986) Calcium metabolism in essential hypertension: relationship to altered renin system activity. Federation Proceedings, 45, 2739-2745. (Pubitemid 17187443)
25. Tomaschitz, A., Pilz, S., Ritz, E., et al. (2010) Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Clinica Chemica Acta, 411, 1354-1360.
26. Vaidya, A., Forman, J.P., &, Williams, J.S., (2010) 25-hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in caucasians. Journal of the Renin-Angiotensin-Aldosterone System, (in press).
27. Gannage-Yared, M.H., Chedid, R., Khalife, S., et al. (2009) Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. European Journal of Endocrinology, 160, 965-971.
28. Nimitphong, H., Chanprasertyothin, S., Jongjaroenprasert, W., et al. (2009) The association between vitamin D status and circulating adiponectin independent of adiposity in subjects with abnormal glucose tolerance. Endocrine, 36, 205-210.
29. Vaidya, A., Forman, J.P., McGowan, L., et al. (2010) Vitamin D is associated with favorable adiponectin and renin-angiotensin system profiles in obesity. Hypertension, 56, e50-e166. (P376).
30. Price, D.A., &, Fisher, N.D., (2003) The renin-angiotensin system in blacks: active, passive, or what? Current Hypertension Reports, 5, 225-230.
31. Holick, M.F., Siris, E.S., Binkley, N., et al. (2005) Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. Journal of Clinical Endocrinology and Metabolism, 90, 3215-3224. (Pubitemid 41014278)
32. Holick, M.F., (2007) Vitamin D deficiency. New England Journal of Medicine, 357, 266-281.
33. Townsend, R.R., Kapoor, S., &, McFadden, C.B., (2007) Salt intake and insulin sensitivity in healthy human volunteers. Clinical Science (London), 113, 141-148. (Pubitemid 47237911)
34. Engeli, S., Negrel, R., &, Sharma, A.M., (2000) Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension, 35, 1270-1277. (Pubitemid 30413663)
35. Lely, A.T., Krikken, J.A., Bakker, S.J., et al. (2007) Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. Journal of Clinical Endocrinology and Metabolism, 92, 1821-1826. (Pubitemid 46997195)
36. Dimitriadis, K., Tsioufis, C., Selima, M., et al. (2009) Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. Journal of Human Hypertension, 23, 668-673.
37. Kawamura, R., Doi, Y., Osawa, H., et al. (2010) Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrology Dialysis and Transplantation, 25, 3236-3240.
38. Bokarewa, M., Nagaev, I., Dahlberg, L., et al. (2005) Resistin, an adipokine with potent proinflammatory properties. Journal of Immunology, 174, 5789-5795. (Pubitemid 40593223)
39. Straburzynska-Lupa, A., Nowak, A., Pilaczynska-Szczesniak, L., et al. (2010) Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clinical Experimental Rheumatology, 28, 19-24.
40. Fargnoli, J.L., Sun, Q., Olenczuk, D., et al. (2010) Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. European Journal of Endocrinology, 162, 281-288.
41. Androulakis, E.S., Tousoulis, D., Papageorgiou, N., et al. (2009) Essential hypertension: is there a role for inflammatory mechanisms? Cardiology Reviews, 17, 216-221.